Bramwell V H, Crowther D, Deakin D P, Swindell R, Harris M
Br J Cancer. 1985 Mar;51(3):301-18. doi: 10.1038/bjc.1985.43.
Over a 10 year period, between 1974-1984, 257 adult cases of tissue sarcoma have been evaluated in the Department of Medical Oncology, Christie Hospital, Manchester. At registration locally advanced or metastatic diseases was present in 162 (63%). The male/female ratio was 1.5:1 and median age 54 years (range 14-85). The commonest sites were lower limb (33%), visceral (21%), trunk (13%), retroperitoneum (12%) and upper limb (10%). Leiomyosarcoma (27%), liposarcoma (14%) malignant fibrous histiocytoma (10%) and neuro plus fibrosarcomas (15%) were the most frequent histological subtypes. A high proportion of uterine sarcomas (17%) is a point of distinction from many other series. Histological grade was specified in 72% of cases and the distribution (Grade I--27%; II--6%; III--67%) reflected a referral bias towards advanced disease. Local resection of the primary tumour was performed in 76% of cases. In many instances this only amounted to 'shelling out' and true compartmental excisions were rare. Amputation was performed in 31% of patients with limb sarcomas. Ninety-eight patients (38%) had experienced one or more local recurrences prior to referral and the overall local recurrence rate was 56%. Suitable patients (78%) received chemotherapy, 50% entering multicentre trials in collaboration with the EORTC. The commonest regime used in patients with advanced disease was CYVADIC which produced an overall response rate of 37%. Ifosfamide, used as a single agent in 16 patients, induced 3CR and 5PR for an overall response rate of 50%. When used in combination with MTX and VADIC, there was no difference in response rate, but numbers in these pilot studies were small. Seventeen high risk patients received adjuvant chemotherapy with VAC, but the results (11 relapses) were disappointing. An EORTC trial, comparing adjuvant CYVADIC chemotherapy with control has accrued 307 patients, 49 of these from the Christie Hospital. Preliminary results within this centre - 13/25 relapses in the control arm, 5/23 in the chemotherapy arm-suggest an advantage for chemotherapy but the data are statistically not significant. Post-operative radical radiotherapy after resection of the primary tumour or local recurrence was performed in 51 patients, with local control in 65% of cases, although metastases developed in 41%. At the time of analysis (1st April 1984) 98 (38%) were alive, of whom 72 showed no evidence of disease and 52 had never relapsed. Malignant disease was the cause of death in 92%. Overall survival was not influenced by sex, but patients less than 40 years of age fared significantly better (P less than 0.001).(ABSTRACT TRUNCATED AT 400 WORDS)
在1974年至1984年的10年期间,曼彻斯特克里斯蒂医院肿瘤内科对257例成人软组织肉瘤病例进行了评估。登记时,162例(63%)存在局部晚期或转移性疾病。男女比例为1.5:1,中位年龄54岁(范围14 - 85岁)。最常见的部位是下肢(33%)、内脏(21%)、躯干(13%)、腹膜后(12%)和上肢(10%)。平滑肌肉瘤(27%)、脂肪肉瘤(14%)、恶性纤维组织细胞瘤(10%)以及神经纤维肉瘤(15%)是最常见的组织学亚型。子宫肉瘤比例较高(17%),这是与许多其他系列研究不同的一点。72%的病例明确了组织学分级,其分布情况(I级 - 27%;II级 - 6%;III级 - 67%)反映了对晚期疾病的转诊偏向。76%的病例对原发肿瘤进行了局部切除。在许多情况下,这仅相当于“剜除术”,真正的间室切除术很少见。31%的肢体肉瘤患者接受了截肢手术。98例(38%)患者在转诊前经历过一次或多次局部复发,总体局部复发率为56%。合适的患者(78%)接受了化疗,50%的患者参与了与欧洲癌症研究与治疗组织(EORTC)合作的多中心试验。晚期疾病患者最常用的方案是CYVADIC,总体缓解率为37%。16例患者单独使用异环磷酰胺,诱导出3例完全缓解(CR)和5例部分缓解(PR),总体缓解率为50%。当与甲氨蝶呤(MTX)和VADIC联合使用时,缓解率没有差异,但这些初步研究中的病例数较少。17例高危患者接受了VAC辅助化疗,但结果(11例复发)令人失望。一项EORTC试验比较了辅助CYVADIC化疗与对照组,已招募307例患者,其中49例来自克里斯蒂医院。该中心的初步结果 - 对照组25例中有13例复发,化疗组23例中有5例复发 - 表明化疗有优势,但数据在统计学上不显著。51例患者在原发肿瘤切除或局部复发后接受了术后根治性放疗,65%的病例实现了局部控制,尽管41%的患者出现了转移。在分析时(1984年4月1日),有98例(38%)存活,其中72例无疾病证据,52例从未复发。92%的患者死于恶性疾病。总体生存率不受性别影响,但年龄小于40岁的患者预后明显更好(P < 0.001)。(摘要截取自400字)